Healthpeak Properties, Inc. (NYSE:DOC) Shares Bought by Vert Asset Management LLC

Vert Asset Management LLC grew its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 11.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 304,219 shares of the real estate investment trust’s stock after purchasing an additional 30,461 shares during the quarter. Healthpeak Properties makes up 2.1% of Vert Asset Management LLC’s portfolio, making the stock its 17th largest holding. Vert Asset Management LLC’s holdings in Healthpeak Properties were worth $6,167,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. HM Payson & Co. acquired a new stake in Healthpeak Properties in the third quarter worth $25,000. S.A. Mason LLC bought a new position in shares of Healthpeak Properties during the third quarter worth about $26,000. Rise Advisors LLC acquired a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $29,000. Fortitude Family Office LLC bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $32,000. Finally, Barrett & Company Inc. bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $33,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Stock Performance

Shares of DOC opened at $21.18 on Tuesday. The company has a 50-day moving average of $20.83 and a two-hundred day moving average of $21.56. The stock has a market cap of $14.82 billion, a price-to-earnings ratio of 45.07, a PEG ratio of 2.21 and a beta of 1.14. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. Healthpeak Properties, Inc. has a one year low of $16.01 and a one year high of $23.26.

Wall Street Analyst Weigh In

DOC has been the topic of several analyst reports. Robert W. Baird raised their price target on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and raised their target price for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Royal Bank of Canada boosted their price target on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Wells Fargo & Company lowered their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. Finally, Mizuho reduced their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $24.15.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.